ClinicalTrials.gg
Sign In

Hypophosphatemia clinical trials

The registry lists 53 studies for Hypophosphatemia across more than 10 countries. 16 are recruiting or about to start. 25 of them are mainly about Hypophosphatemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Familial Hypophosphatemic Rickets: 98 studies, 19 open.

Get an email when these change. Save the Hypophosphatemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
23
Recruiting
11
Status unknown
7
Not yet recruiting
5
Active, not recruiting
3
Terminated
3

Phase

Phase 3
6
Phase 2
6
Early Phase 1
3
Phase 4
3
Phase 1
2

Where

United States
18
France
10
Switzerland
6
Italy
4
United Kingdom
4
Germany
3

Who runs them

National Institute of Dental and Craniofacial Research (NIDCR) (3) · University Hospital, Brest (2) · Yale University (2) · Hospices Civils de Lyon (2) · Ain Shams University (2) · Pharmacosmos A/S (2) · Indiana University (1) · University Hospital, Geneva (1)

What is being tested here

Drugs under test in Hypophosphatemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Iron isomaltoside 1000123
Sodium phosphate101
Potassium phosphate101
Dipyridamole101
Phosphates101
Ferric carboxymaltose101
Cinacalcet012
Paricalcitol011
Burosumab011
Iron001

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 11 Hypophosphatemia studies recruiting now, 7 (64%) set no upper age limit and 2 (18%) stop at 75 or younger. 3 (27%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (9%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
102 (18%)2 (18%)
1811 (100%)11 (100%)
3010 (91%)10 (91%)
4010 (91%)10 (91%)
5010 (91%)10 (91%)
6510 (91%)10 (91%)
759 (82%)9 (82%)
858 (73%)8 (73%)

Across all 53 studies, recruiting or not: 17% stop at 75 or younger and 13% at 65; 28% take children; 4% are for women only and 2% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hypophosphatemia studies take

Of 14 observational studies under Hypophosphatemia, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational17 mo6–24 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 53. Browse all 53 → or search them.